North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Outlook
Global Market
Related Markets
North America veterinary active pharmaceutical ingredients manufacturing market highlights
- The North America veterinary active pharmaceutical ingredients manufacturing market generated a revenue of USD 3,678.7 million in 2024.
- The market is expected to grow at a CAGR of 6.1% from 2025 to 2033.
- In terms of segment, in house was the largest revenue generating service type in 2024.
- Contract Outsourcing is the most lucrative service type segment registering the fastest growth during the forecast period.
- Country-wise, Mexico is expected to register the highest CAGR from 2025 to 2033.
North America data book summary
| Market revenue in 2024 | USD 3,678.7 million |
| Market revenue in 2033 | USD 6,244.6 million |
| Growth rate | 6.1% (CAGR from 2025 to 2033) |
| Largest segment | In house |
| Fastest growing segment | Contract Outsourcing |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | In House, Contract Outsourcing |
| Key market players worldwide | Zoetis Inc Class A, SeQuent Scientific, Ofichem Group, The Chem-Pro Group, Siflon Drugs & Pharmaceuticals, Vetpharma, Suanfarma Biotech, Menadiona, Excel Industries |
Other key industry trends
- In terms of revenue, North America region accounted for 39.4% of the global veterinary active pharmaceutical ingredients manufacturing market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 5,074.2 million by 2033.
North America is anticipated to dominate the veterinary Active Pharmaceutical Ingredients (API) manufacturing market over the forecast period. Zoonoses (zoonotic diseases) pose a significant burden in the region as they are an additional threat to public health, and animals are often the source of diseases.
According to the CDC, in 2021, three of every four new or emerging infectious diseases in humans were reported to be animal-borne, and more than six of every ten existing infectious diseases in humans can be transmitted from animals.
For instance, the North American Pet Health Insurance Association (NAPHIA) raises awareness about pet health insurance coverage and develops & explores partnerships to address challenges faced by the animal healthcare industry.
No credit card required*
Publish Date: Nov 25, 2025
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Scope
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Zoetis Inc Class A | View profile | 14,100 | 10 Sylvan Way, Parsippany, NJ, United States, 07054 | www.zoetis.com |
| Menadiona | View profile | 51-100 | Barcelona, Catalonia, Spain, Europe | www.menadiona.com/ |
| SeQuent Scientific | View profile | 1001-5000 | Bangalore, Karnataka, India, Asia | sequent.in |
| Ofichem Group | View profile | 51-100 | Ter Apel, Groningen, The Netherlands, Europe | ofichem.com |
| The Chem-Pro Group | View profile | 501-1000 | Mumbai, Maharashtra, India, Asia | www.chemprogroup.com |
| Siflon Drugs & Pharmaceuticals | View profile | 11-50 | Hyderabad, Andhra Pradesh, India, Asia | siflonpharma.com |
| Vetpharma | View profile | 11-50 | Barcelona, Catalonia, Spain, Europe | vetpharma.com |
| Suanfarma Biotech | View profile | 251-500 | Alcobendas, Madrid, Spain, Europe | www.suanfarma.com |
| Excel Industries | View profile | 501-1000 | Mumbai, Maharashtra, India, Asia | www.excelind.co.in |
North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook will help companies and investors design strategic landscapes.
In House was the largest segment with a revenue share of 59.18% in 2024.
Horizon Databook has segmented the North America veterinary active pharmaceutical ingredients manufacturing market based on in house, contract outsourcing covering the revenue growth of each sub-segment from 2021 to 2033.
North America is anticipated to dominate the veterinary Active Pharmaceutical Ingredients (API) manufacturing market over the forecast period. Zoonoses (zoonotic diseases) pose a significant burden in the region as they are an additional threat to public health, and animals are often the source of diseases.
According to the CDC, in 2021, three of every four new or emerging infectious diseases in humans were reported to be animal-borne, and more than six of every ten existing infectious diseases in humans can be transmitted from animals.
For instance, the North American Pet Health Insurance Association (NAPHIA) raises awareness about pet health insurance coverage and develops & explores partnerships to address challenges faced by the animal healthcare industry.
- North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Service Type Outlook (Revenue, USD Million , 2021-2033)
- In House
- Contract Outsourcing
- North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Synthesis Type Outlook (Revenue, USD Million , 2021-2033)
- Chemical Based API
- Biological API
- HPAPI
- North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Therapeutic Category Outlook (Revenue, USD Million , 2021-2033)
- Antiparasitics
- Anti-infectives
- NSAIDs
- Others
- North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Animal Type Outlook (Revenue, USD Million , 2021-2033)
- Companion Animals
- Production Animals
Reasons to subscribe to Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook databook
- Our clientele includes a mix of Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market, 2021-2033 (US$M)
North America Service Type - Veterinary Active Pharmaceutical Ingredients Manufacturing Market Statistics, 2024 - 2033 (US$M)
